Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
Follow BDX
Becton, Dickinson and Company (BDX) P/S ratio
As of 16 October 2026, Becton, Dickinson and Company (BDX) trades at a P/S ratio of 2.4×. Over the past ten years it has ranged from 1.8× (June 2026) to 3.7× (September 2018); the current reading is higher than 24% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.9× | (28.80%) |
| FY2024 | 2.7× | (9.11%) |
| FY2023 | 3.0× | 13.18% |
| FY2022 | 2.6× | (7.20%) |
| FY2021 | 2.9× | (7.95%) |
| FY2020 | 3.1× | 2.24% |
| FY2019 | 3.0× | (7.58%) |
| FY2018 | 3.3× | 20.26% |
| FY2017 | 2.7× | 16.04% |
| FY2016 | 2.3× | 17.19% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 1.9× | (6.84%) |
| Mar 2026 | 2.0× | 0.20% |
| Dec 2025 | 2.0× | 2.54% |
| Sep 2025 | 1.9× | (1.27%) |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| MDLN Medline Inc. compare | 1.0× |
| BAX Baxter International Inc. compare | 1.1× |
| SOLV Solventum Corporation compare | 1.8× |
| BDX Becton, Dickinson and Company | 2.4× |
| ALC Alcon compare | 3.0× |
| RMD ResMed Inc. compare | 6.2× |
| WST West Pharmaceutical Services, Inc. compare | 8.1× |
| RGEN Repligen Corporation compare | 12.6× |
| ISRG Intuitive Surgical, Inc. compare | 13.7× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on BDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement